Skip to main content
PMC home page
The BMJ logoLink to The BMJ
. 1995 Jun 10;310(6993):1491–1495. doi: 10.1136/bmj.310.6993.1491

Evidence of an association between non-Hodgkin's lymphoma and skin cancer.

J Adami 1, M Frisch 1, J Yuen 1, B Glimelius 1, M Melbye 1
PMCID: PMC2549874  PMID: 7787593

Abstract

OBJECTIVE--To investigate a possible link between exposure to ultraviolet light and the almost epidemic increase in non-Hodgkin's lymphoma worldwide. Because ultraviolet light is known to cause skin cancers, the association between non-Hodgkin's lymphoma and skin cancer was studied. DESIGN--Secondary occurrence of either malignant melanoma or squamous cell skin cancer in cohorts of patients with a first diagnosis of either non-Hodgkin's lymphoma or chronic lymphocytic leukaemia, and vice versa, were studied. Expected numbers of subsequent cancers were calculated by sex, age, and period specific national incidence rates multiplied by the person years under observation in the cohorts. SETTING--Denmark (1943-89) and Sweden (1958-89). SUBJECTS--Four population based cohorts identified in the nationwide cancer registries (34,641 people with non-Hodgkin's lymphoma, 17,400 with chronic lymphocytic leukaemia, 34,989 with malignant melanoma, 25,980 with squamous cell skin cancer). A total of 562,085 person years were accrued for the analysis. MAIN OUTCOME MEASURES--The ratios of observed to expected cancers (the standardised incidence ratio) served as a measure of the relative risk. RESULTS--The relative risk for developing squamous cell skin cancer was 5.5 (95% confidence interval 4.6 to 6.6) among patients with non-Hodgkin's lymphoma and 8.6 (7.2 to 10.3) among patients with chronic lymphocytic leukaemia. The relative risks remained high over more than 15 years of follow up. Relative risks for malignant melanoma were 2.4 (1.8 to 3.2) for patients with non-Hodgkin's lymphoma and 3.1 (2.1 to 4.4) for patients with chronic lymphocytic leukaemia. After squamous cell skin cancer had been diagnosed there was a twofold excess risk for non-Hodgkin's lymphoma and chronic lymphocytic leukaemia. By contrast, in each of the cohorts the general cancer risks excluding skin and lymphoproliferative malignancies were close to the expected. CONCLUSIONS--The occurrence of non-Hodgkin's lymphoma and skin cancer are strongly associated; this supports the hypothesis that the secular increase in exposure to ultraviolet light may have contributed to the increasing incidence of non-Hodgkin's lymphoma in recent decades.

Full text

PDF
1491

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blomberg J., Möller T., Olsson H., Anderson H., Jonsson M. Cancer morbidity in blood recipients--results of a cohort study. Eur J Cancer. 1993;29A(15):2101–2105. doi: 10.1016/0959-8049(93)90042-e. [DOI] [PubMed] [Google Scholar]
  2. Cartwright R., McNally R., Staines A. The increasing incidence of non-Hodgkin's lymphoma (NHL): the possible role of sunlight. Leuk Lymphoma. 1994 Aug;14(5-6):387–394. doi: 10.3109/10428199409049694. [DOI] [PubMed] [Google Scholar]
  3. Casabona J., Melbye M., Biggar R. J. Kaposi's sarcoma and non-Hodgkin's lymphoma in European AIDS cases. No excess risk of Kaposi's sarcoma in Mediterranean countries. Int J Cancer. 1991 Jan 2;47(1):49–53. doi: 10.1002/ijc.2910470110. [DOI] [PubMed] [Google Scholar]
  4. Cerhan J. R., Wallace R. B., Folsom A. R., Potter J. D., Munger R. G., Prineas R. J. Transfusion history and cancer risk in older women. Ann Intern Med. 1993 Jul 1;119(1):8–15. doi: 10.7326/0003-4819-119-1-199307010-00002. [DOI] [PubMed] [Google Scholar]
  5. Coleman M. Chemotherapy for large-cell lymphoma: optimism and caution. Ann Intern Med. 1985 Jul;103(1):140–142. doi: 10.7326/0003-4819-103-1-140. [DOI] [PubMed] [Google Scholar]
  6. Ebbesen P. Enhanced lymphoma incidence in BALB/c mice after ultraviolet light treatment. J Natl Cancer Inst. 1981 Nov;67(5):1077–1078. [PubMed] [Google Scholar]
  7. Frisch M., Olsen J. H., Melbye M. Malignancies that occur before and after anal cancer: clues to their etiology. Am J Epidemiol. 1994 Jul 1;140(1):12–19. doi: 10.1093/oxfordjournals.aje.a117154. [DOI] [PubMed] [Google Scholar]
  8. Gail M. H., Pluda J. M., Rabkin C. S., Biggar R. J., Goedert J. J., Horm J. W., Sondik E. J., Yarchoan R., Broder S. Projections of the incidence of non-Hodgkin's lymphoma related to acquired immunodeficiency syndrome. J Natl Cancer Inst. 1991 May 15;83(10):695–701. doi: 10.1093/jnci/83.10.695. [DOI] [PubMed] [Google Scholar]
  9. Hakulinen T., Isomaki H., Knekt P. Rheumatoid arthritis and cancer studies based on linking nationwide registries in Finland. Am J Med. 1985 Jan 21;78(1A):29–32. doi: 10.1016/0002-9343(85)90242-6. [DOI] [PubMed] [Google Scholar]
  10. Hersey P., Bradley M., Hasic E., Haran G., Edwards A., McCarthy W. H. Immunological effects of solarium exposure. Lancet. 1983 Mar 12;1(8324):545–548. doi: 10.1016/s0140-6736(83)92808-8. [DOI] [PubMed] [Google Scholar]
  11. Hersey P., Haran G., Hasic E., Edwards A. Alteration of T cell subsets and induction of suppressor T cell activity in normal subjects after exposure to sunlight. J Immunol. 1983 Jul;131(1):171–174. [PubMed] [Google Scholar]
  12. Hoover R., Fraumeni J. F., Jr Risk of cancer in renal-transplant recipients. Lancet. 1973 Jul 14;2(7820):55–57. doi: 10.1016/s0140-6736(73)93256-x. [DOI] [PubMed] [Google Scholar]
  13. Kinlen L. J., Sheil A. G., Peto J., Doll R. Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs. Br Med J. 1979 Dec 8;2(6203):1461–1466. doi: 10.1136/bmj.2.6203.1461. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kripke M. L. Effects of UV radiation on tumor immunity. J Natl Cancer Inst. 1990 Sep 5;82(17):1392–1396. doi: 10.1093/jnci/82.17.1392. [DOI] [PubMed] [Google Scholar]
  15. Kripke M. L. Immunologic mechanisms in UV radiation carcinogenesis. Adv Cancer Res. 1981;34:69–106. doi: 10.1016/s0065-230x(08)60239-0. [DOI] [PubMed] [Google Scholar]
  16. Martinsson U., Glimelius B., Hagberg H., Sundström C. Primarily asymptomatic low-grade non-Hodgkin lymphomas: prediction of symptom-free survival and total survival. Eur J Haematol. 1989 Oct;43(4):332–338. doi: 10.1111/j.1600-0609.1989.tb00308.x. [DOI] [PubMed] [Google Scholar]
  17. Martinsson U., Glimelius B., Sundström C. Lymphoma incidence in a Swedish county during 1969-1987. Acta Oncol. 1992;31(3):275–282. doi: 10.3109/02841869209108173. [DOI] [PubMed] [Google Scholar]
  18. Opelz G., Henderson R. Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet. 1993 Dec 18;342(8886-8887):1514–1516. doi: 10.1016/s0140-6736(05)80084-4. [DOI] [PubMed] [Google Scholar]
  19. Osterlind A. Etiology and epidemiology of melanoma and skin neoplasms. Curr Opin Oncol. 1991 Apr;3(2):355–359. [PubMed] [Google Scholar]
  20. Parkin D. M., Pisani P., Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer. 1993 Jun 19;54(4):594–606. doi: 10.1002/ijc.2910540413. [DOI] [PubMed] [Google Scholar]
  21. Penn I. Secondary neoplasms as a consequence of transplantation and cancer therapy. Cancer Detect Prev. 1988;12(1-6):39–57. [PubMed] [Google Scholar]
  22. Romerdahl C. A., Donawho C., Fidler I. J., Kripke M. L. Effect of ultraviolet-B radiation on the in vivo growth of murine melanoma cells. Cancer Res. 1988 Jul 15;48(14):4007–4010. [PubMed] [Google Scholar]
  23. Shapiro R. S., McClain K., Frizzera G., Gajl-Peczalska K. J., Kersey J. H., Blazar B. R., Arthur D. C., Patton D. F., Greenberg J. S., Burke B. Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation. Blood. 1988 May;71(5):1234–1243. [PubMed] [Google Scholar]
  24. Zheng T., Mayne S. T., Boyle P., Holford T. R., Liu W. L., Flannery J. Epidemiology of non-Hodgkin lymphoma in Connecticut. 1935-1988. Cancer. 1992 Aug 15;70(4):840–849. doi: 10.1002/1097-0142(19920815)70:4<840::aid-cncr2820700420>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES